Hi-Tech acquires private branded drug company
This article was originally published in Scrip
Executive Summary
Hi-Tech Pharmacal has acquired the private US branded speciality company ECR Pharmaceuticals for $5.1 million plus up to $4million in performance incentives relating to the Virginia-based company's product sales and profits.